Malignant Skin Neoplasm — Trials

Malignant Skin Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 320
Recruiting: 171
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (202)

clinicaltrialsPublishedShowing 451–460 of 460 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00535470	An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides	completed	Phase 2	100	Yaupon TherapeuticsINDUSTRY	1	Aug 9, 2012	clinicaltrials
NCT00925314	A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma	unknown	Phase 2	20	Cosmo BioscienceINDUSTRY	1	Feb 13, 2012	clinicaltrials